Pharma giant also insists on indemnity against its own negligence in hardball negotiations with Latin American countries. In Argentina and Brazil, Pfizer demanded the use of sovereign assets as collateral to cover potential future legal costs. In Peru, negotiations took almost six months and included indemnity against adverse effects and delays in delivering the batches. A report led by the Bureau of Investigative Journalism and OjoPúbico in Peru.

Madlen Davies

@madlendavies madlendavies@tbij.com

Rosa Furneaux

@rosafurneaux rosafurneaux@tbij.com

Jill Langlois

@JillLanglois langlois.jill@gmail.com

Iván Ruiz

@iruiz ivanruiz24@gmail.com

Ernesto Cabral

@ernestocabralm ernesto@ojo-publico.com

Nelly Luna Amancio

@nellylun nellyluna@ojo-publico.com

Madlen Davies @madlendavies madlendavies@tbij.com

Rosa Furneaux @rosafurneaux rosafurneaux@tbij.com

Jill Langlois @JillLanglois langlois.jill@gmail.com

Iván Ruiz @iruiz ivanruiz24@gmail.com

Ernesto Cabral @ernestocabralm ernesto@ojo-publico.com

Nelly Luna Amancio @nellylun nellyluna@ojo-publico.com

24 Febrero, 2021